Skip to content

Distress screening in Head and Neck Cancer patients before and after undergoing treatment.

Distress screening in Head and Neck Cancer patients undergoing active cancer directed treatment and impact of referral to psycho-oncology and palliative care. - Distress in Head and Neck Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2016/01/006549
Enrollment
600
Registered
2016-01-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Head and neck cancer patients with histological confirmation

Interventions

Intervention1: NIL: NIL

Sponsors

Tata Memorial Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Part A: 1)Head and neck cancer patients with histological confirmation. 2)Planned to receive curative active cancer directed treatment. 3)Aware of their diagnosis and treatment plan. 4)Willingness to participate in study and sign ICF. 5)Age >18 years. 6)ECOG 2 or less Part B : 1) Patients who score 4 or above on Distress Thermometer. 2) Willingness to participate in study 3) Reliable to complete the stipulated follow up.

Exclusion criteria

Exclusion criteria: Part A: 1)Prior history of treatment â?? radiotherapy / chemotherapy. Part B: 1)Pre-existent diagnosed psychiatric disorder. 2)Patients on antidepressants, anti-psychotics for a pre-existent diagnosed psychiatric disorder. 3)Poorly controlled co-morbid conditions requiring intensive medical management. Suicidal tendencies

Design outcomes

Primary

MeasureTime frame
PART A â?¢Frequency and percentage of patients having clinically significant distress (Score of 4 and above on Distress Thermometer) PART B â?¢Change in distress scores on DT at baseline and 6 months in both groupsTimepoint: Proportion of Clinically significant distress at base line, first follow-up.

Secondary

MeasureTime frame
Change in NCCN Problem checklist & ESAS Scores & QOL C30 & HN 35 â?¢Correlation of presence and absence of clinically significant distress with loco regional control of diseaseTimepoint: Proportion of Clinically significant distress at base line, first follow-up.

Countries

India

Contacts

Public ContactDr J P Agarwal

Tata Memorial Centre

saketp25@gmail.com02224177164

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 8, 2026